MedPath

UNIVERSITY OF HOUSTON

UNIVERSITY OF HOUSTON logo
🇺🇸United States
Ownership
Private
Established
1927-01-01
Employees
10K
Market Cap
-
Website
http://www.uh.edu

Clinical Trials

95

Active:1
Completed:49

Trial Phases

5 Phases

Early Phase 1:2
Phase 1:3
Phase 2:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (92 trials with phase data)• Click on a phase to view related trials

Not Applicable
84 (91.3%)
Phase 1
3 (3.3%)
Early Phase 1
2 (2.2%)
Phase 4
2 (2.2%)
Phase 2
1 (1.1%)

Shaping Habitual Impulses For a Tobacco-free Style

Not Applicable
Not yet recruiting
Conditions
ST+ABR
ST+SHAM
ST-only
First Posted Date
2025-06-17
Last Posted Date
2025-06-17
Lead Sponsor
University of Houston
Target Recruit Count
300
Registration Number
NCT07025772
Locations
🇺🇸

RESTORE Laboratory: Research on Emotion, Substance Use Treatment Outcomes, Rehabilitation, and Empowerment, Houston, Texas, United States

Enhancing Smoking Cessation for African American People Everywhere

Phase 2
Not yet recruiting
Conditions
ESCAPE Intervention+NRT
quitSTART Intervention+NRT
CTRL+NRT
First Posted Date
2025-06-17
Last Posted Date
2025-07-25
Lead Sponsor
University of Houston
Target Recruit Count
300
Registration Number
NCT07024992
Locations
🇺🇸

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Smart Olfaction App to Reduce Relapse

Early Phase 1
Not yet recruiting
Conditions
Nicotine Dependence
Interventions
Device: Ad Libitum Use followed by Instructed Use of the Inspire Device
Device: Instructed Use followed by Ad Libitum Use of the Inspire Device
Device: Smart-T Smoking Cessation App with the Inspire Device Condition
Device: Smart-T Smoking Cessation App Without the Inspire Device Condition
Device: Inspire Device
First Posted Date
2025-06-05
Last Posted Date
2025-07-23
Lead Sponsor
University of Houston
Target Recruit Count
132
Registration Number
NCT07007195
Locations
🇺🇸

RESTORE Laboratory: Research on Emotion, Substance Use Treatment Outcomes, Rehabilitation, and Empowerment, Houston, Texas, United States

Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study

Not Applicable
Recruiting
Conditions
Childhood Obesity
First Posted Date
2025-04-09
Last Posted Date
2025-04-09
Lead Sponsor
University of Houston
Target Recruit Count
300
Registration Number
NCT06918821
Locations
🇺🇸

University of Houston, Houston, Texas, United States

Emergent Bilinguals: Child Language Proficiency and Language of Treatment

Not Applicable
Recruiting
Conditions
Developmental Language Disorder
Language Impairment
First Posted Date
2025-03-10
Last Posted Date
2025-03-10
Lead Sponsor
University of Houston
Target Recruit Count
40
Registration Number
NCT06866223
Locations
🇺🇸

University of Houston, Houston, Texas, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

News

Fentanyl Vaccine Poised for Clinical Trials, Offering Hope in Opioid Crisis

A fentanyl vaccine developed at the University of Houston is set to enter clinical trials in mid-2025, aiming to prevent the opioid from reaching the brain.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.